BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 21
• 22
• 23
• 24
• 27
• 28
• 29

• Prime Therapeutics President and CEO Eric Elliott Cites Urgent Need for “True Integration” of PBMs, Plans at 2012 PCMA Managed Markets Educational Forum

  February 8, 2012

   · 

  2 min read
• Business

  Savient Pharmaceuticals, Inc. to Hold Fourth Quarter and Year-End 2011 Financial Results Conference Call on Monday, February 27, 2012

  February 8, 2012

   · 

  2 min read
• World-Class Laboratories Rely on Dako A/S’s New Artisan(TM) Link Pro for Special Stains Diagnostics

  February 8, 2012

   · 

  2 min read
• Genetown

  Pressure BioSciences, Inc. Closes $800,000 Private Placement

  February 8, 2012

   · 

  1 min read
• Pharm Country

  Taglich Brothers Initiates Coverage on Pivotal Therapeutics Inc.

  February 8, 2012

   · 

  2 min read
• Business

  VistaGen Therapeutics, Inc. Increases Its Drug Rescue Opportunities With Right-of-First-Offer Agreement With Cato BioVentures and Cato Research

  February 8, 2012

   · 

  5 min read
• RelayHealth and McKesson Specialty Health Administer First Class-Wide Transmucosal Immediate Release Fentanyl REMS Program

  February 8, 2012

   · 

  1 min read
• Biotech Bay

  StemCells Inc. to Present at 2012 Biotechnology Industry Organization (BIO) CEO Investor Conference

  February 8, 2012

   · 

  1 min read
• Business

  Immunomedics, Inc. Announces Second Quarter Fiscal 2012 Results and Clinical Program Developments

  February 8, 2012

   · 

  1 min read
• Business

  Bend Research Signs License Agreement With Eli Lilly and Company

  February 8, 2012

   · 

  2 min read